alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-GlcpNAc

Term ID

CHEBI:62263

Synonyms

(Gal)1 (GlcNAc)1 (LFuc)1
2'-fucosyllactose
6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-D-GlcNAc
alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-D-glucopyranose
alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosamine
Anti H type 2 trisaccharide
Fucalpha(1-2)Galbeta(1-4)GlcNAc
Fucalpha1-2Galbeta1-4GlcNAc
Lewis H-2 antigen

Definition

An amino trisaccharide consisting of α-L-fucose, β-D-galactose and N-acetyl-D-glucosamine residues joined by sequential (1→2)- and (1→4)-linkages.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-GlcpNAc

Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-GlcpNAc

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-GlcpNAc

Phenotype affecting alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-GlcpNAc

Human Disease Model